Dr. Satoshi Yoda is a Principal Scientist at Lime Therapeutics. Prior to joining the team, he was a Principal Scientist in the Discovery Biology team at Tango Therapeutics, where he led an early drug discovery program. Previously, he served as an Instructor at Harvard Medical School and Massachusetts General Hospital. Under the supervision of Dr. Aaron Hata and Dr. Alice Shaw, he was dedicated to translational research and published 20 papers contributing to advances in targeted therapy for ALK/ROS1/RET fusion–positive lung cancer. In 2018, he was awarded the Lung Cancer Research Foundation Scientific Grant. Before moving to the United States in 2015, he practiced as a thoracic oncologist in Japan and led investigator-initiated clinical trials for lung cancer. Dr. Yoda earned his MD and PhD from Keio University in Japan.